LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Partnerships Ansa Biotechnologies recently partnered with Innovative Genomics Institute (IGI) to advance research through the manufacturing of DNA sequences with complex features. This collaboration presents an opportunity to explore joint projects and expand market reach by leveraging complementary expertise.

New Leadership With the appointment of Jason T. Gammack as the CEO, Ansa Biotechnologies is gearing up to launch a rapid enzymatic synthesis service for complex DNA sequences. Engaging with the new leadership team can open avenues for introducing solutions tailored to meet evolving customer needs and preferences.

Strategic Board Expansion The addition of Matthew F. McManus, M.D., Ph.D., as the Independent Director and Chairperson of the Board strengthens Ansa Biotechnologies' strategic decision-making capabilities. Interacting with the expanded board can offer insights into future growth plans and create opportunities for collaborative ventures.

Talented Leadership Recruitment Ansa Biotechnologies has recently appointed key executives like Lorna Neilson as the Vice President of Corporate Development and Jeremiah Hanes as the Senior Vice President of Research & Development. Building relationships with these experienced leaders can pave the way for tailored solutions and strategic partnerships.

Fundraising Success Having raised $68 million to launch a DNA production service, Ansa Biotechnologies demonstrates strong investor confidence and financial stability. Exploring potential collaboration opportunities or service offerings in line with their expansion plans can be mutually beneficial.

Similar companies to Ansa Biotechnologies, Inc.

Ansa Biotechnologies, Inc. Tech Stack

Ansa Biotechnologies, Inc. uses 7 technology products and services including Squarespace, Squarespace Commerce, Stimulus, and more. Explore Ansa Biotechnologies, Inc.'s tech stack below.

  • Squarespace
    Content Management System
  • Squarespace Commerce
    E-commerce
  • Stimulus
    Javascript Frameworks
  • Choices
    Javascript Libraries
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • HSTS
    Security

Media & News

Ansa Biotechnologies, Inc.'s Email Address Formats

Ansa Biotechnologies, Inc. uses at least 1 format(s):
Ansa Biotechnologies, Inc. Email FormatsExamplePercentage
First@ansabio.comJohn@ansabio.com
65%
F.Last@ansabio.comJ.Doe@ansabio.com
24%
FLast@ansabio.comJDoe@ansabio.com
8%
Last@ansabio.comDoe@ansabio.com
3%

Frequently Asked Questions

Where is Ansa Biotechnologies, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc.'s main headquarters is located at 1198 65th St Suite 250 Emeryville, California 94608 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Ansa Biotechnologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc.'s official website is ansabio.com and has social profiles on LinkedIn.

How much revenue does Ansa Biotechnologies, Inc. generate?

Minus sign iconPlus sign icon
As of October 2024, Ansa Biotechnologies, Inc.'s annual revenue reached $3.8M.

What is Ansa Biotechnologies, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ansa Biotechnologies, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2024, Ansa Biotechnologies, Inc. has approximately 85 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. T. G.Chief Executive Officer: D. A.Chief Business Officer: L. N.. Explore Ansa Biotechnologies, Inc.'s employee directory with LeadIQ.

What industry does Ansa Biotechnologies, Inc. belong to?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc. operates in the Biotechnology Research industry.

What technology does Ansa Biotechnologies, Inc. use?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc.'s tech stack includes SquarespaceSquarespace CommerceStimulusChoicesRSSOpen GraphHSTS.

What is Ansa Biotechnologies, Inc.'s email format?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc.'s email format typically follows the pattern of . Find more Ansa Biotechnologies, Inc. email formats with LeadIQ.

How much funding has Ansa Biotechnologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Ansa Biotechnologies, Inc. has raised $68M in funding. The last funding round occurred on Apr 11, 2022 for $68M.

When was Ansa Biotechnologies, Inc. founded?

Minus sign iconPlus sign icon
Ansa Biotechnologies, Inc. was founded in 2018.
Ansa Biotechnologies, Inc.

Ansa Biotechnologies, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability.

Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page. 

Section iconCompany Overview

Headquarters
1198 65th St Suite 250 Emeryville, California 94608 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $68M

    Ansa Biotechnologies, Inc. has raised a total of $68M of funding over 6 rounds. Their latest funding round was raised on Apr 11, 2022 in the amount of $68M.

  • $10M

    Ansa Biotechnologies, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $68M

    Ansa Biotechnologies, Inc. has raised a total of $68M of funding over 6 rounds. Their latest funding round was raised on Apr 11, 2022 in the amount of $68M.

  • $10M

    Ansa Biotechnologies, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.